Pregled bibliografske jedinice broj: 1170670
New candidate biomarker of nephritis risk assessment in children with Henoch-Schönlein purpura
New candidate biomarker of nephritis risk assessment in children with Henoch-Schönlein purpura // Archives of disease in childhood, 106 (2021), Suppl 2
Zagreb, Hrvatska, 2021. str. A183-A184 doi:10.1136/archdischild-2021-europaediatrics.439 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1170670 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
New candidate biomarker of nephritis risk assessment
in children with Henoch-Schönlein purpura
Autori
Frković, Marijan ; Mlinarić, Ana ; Sršen, Saša ; Gagro, Alenka ; Rogić, Dunja ; Jelušić Marija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Archives of disease in childhood, 106 (2021), Suppl 2
/ - , 2021, A183-A184
Skup
10th Congress of European Paediatric Association EPA/UNEPSA jointly held with 14 th Congress of Croatian Paediatric Society
Mjesto i datum
Zagreb, Hrvatska, 07.10.2021. - 09.10.2021
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Henoch-Schönlein purpura ; vasculitis ; pediatrics
Sažetak
Goal: Henoch-Schönlein purpura (HSP) is the most common vasculitis of the childhood. Among all possible symptoms/complications, nephritis (HSPN) is the main and almost only cause of morbidity and mortality in HSP. The aim of the study was to investigate the value of erythrocyte glutathione S-transferase (e-GST) activity as an early predictor of HSPN. Methods: Ninety-seven children with HSP were enrolled into the study. The control group consisted of 52 children without clinical and laboratory signs of inflammation. In all participants e-GST activity was determined spectrometrically from the whole blood samples, after incubation with a commercial GST assay. Results: At the beginning of the disease the e-GST activity was significantly higher in HSPN patients who developed the nephritis during the six month follow up period, compared to the group of HSP patients without signs of nephritis: median (interquartile range) 5, 70 U/mgHb (4, 38-7, 50 U/mgHb) compared to 3, 10 U/mgHb (2, 20-4, 20 U/mgHb) ; P<0, 001. Similar results were obtained after the comparison of the HSPN patients and control group: 5, 70 U/mgHb (4, 38-7, 50 U/mgHb) vs.3, 13 U/mgHb (1, 91-4, 20 U/mgHb) ; P<0, 001. There were no statistically significant differences between the group of HSP patients without nephritis and control group (P=0, 837). During the follow up period, a significant decrease of e-GST activity was observed in the HSPN patients, but it was still significantly higher compared to the group of HSP patients without nephritis (P<0, 001/P<0, 001). Conclusion: e-GST activity is a reliable, independent marker of early nephritis risk assessment in children with HSP. As a sensitive, specific and feasible laboratory test, it has potential practical utility in the diagnostic algorithm and monitoring of the children with HSP.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Klinika za dječje bolesti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE